Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-facing content or functionality appears to change.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedGaucher disease type I has been added as a related condition term on the study page.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice. The earlier Revision: v3.4.1 notice was also removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedNotice about a lapse in government funding and status updates (top-of-page notice) has been added, and the site revision note has been updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.